Financial
FY2026 revenue £431.1m (+17.4%); operating margin 12.7%; net income £42.5m.
No debt; £89.1m cash.
HQ United Kingdom · Europe
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
FY2026 revenue £431.1m (+17.4%); operating margin 12.7%; net income £42.5m.
No debt; £89.1m cash.
Source: official results release · Year ended 2026-03-31 · Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
| Year | Revenue | Growth | Operating profit | Net income | Covers |
|---|---|---|---|---|---|
| FY2026 | £431.1m | +17.4% | £54.8m | £42.5m | Kainos Group |
Products not yet catalogued.
FY2026 revenue £431.1m (+17.4%); operating margin 12.7%; net income £42.5m.
No debt; £89.1m cash.
No adverse media involving Kainos found in HSH's search of the last 24 months.
No data breaches, cyber incidents or regulator action involving Kainos found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
IT services supplier; no regulatory or clinical safety actions found in the last 24 months.
Oct 2025: Kainos won a contract of up to three years under NHS England's Digital Prevention Service Portfolio, covering the Digital NHS Health Check, NHS App vaccination and screening records, and vaccination digital services.
No competitors linked yet.